INTRODUCTION
In 2000, the National Cancer Institute (NCI) launched the Special Population Networks (SPN) as a Request for Funding Announcement (RFA-05-012) to address community needs for cancer information and the NCI's desire to obtain community-based answers to research questions and promote training opportunities for racial/ethnic minority and underserved researchers in populations with an unequal burden of cancer. 1 The Asian American Network for Cancer Awareness, Research, and Training (AANCART) was fortunate to be among the funded networks and represented the first time that the NCI had funded a national network focused on the Asian American cancer burden. 2 Between 2006 and 2010, the NCI followed with the Community Network Programs and followed with the Community Networks Program Centers (CNPCs) program (RFA-CA-09-032) between 2010 and 2015. AANCART reports up to 2010 have been published previously, [3] [4] [5] including shaping an understanding of the science of cancer health disparities, 6 and thus will not be repeated here. The purpose of this article was to describe AANCART's cumulative contributions to mitigating Asian American cancer health disparities, especially since 2010, with respect to the NCI's expectations in cancer awareness, outreach, research, and training and highlight unanticipated outcomes. The NCI's expectations were expressed in terms of the Specific Aims it approved for AANCART for the cycle beginning in 2010. These aims were as follows: Introduction 1. In Infrastructure, to establish The National Center for Reducing Asian American Cancer Health Disparities (AANCART) whose purpose is to conduct outreach, research and training by building upon AANCART's preceding 9 years as an NCI-funded Community Network Program with its record of leadership, significant accomplishments, earned community trust, and established network of community-academic partnerships. 2. In Outreach, to create and increase access to culturally appropriate, linguistically specific, and evidence-based materials designed to increase knowledge about and use of beneficial procedures to reduce cancer disparities and related comorbid conditions among Asian Americans. 3. In Research, to conduct, foster, and disseminate evidence-based intervention research to reduce the unnecessary cancer burden confronting Asian Americans. (The program project, "Liver Cancer Control Interventions for Asian Americans" [P01CA109091-A1] that emerged from AANCART is also cited because it contributed to the research mission of the cofunders, the NCI and the National Institute on Minority Health and Health Disparities.) 4. In Training, to nurture and mentor new and early stage investigators (NESIs) in community-based participatory research (CBPR) who will submit peer-reviewed proposals and obtain funding to conduct research to reduce health disparities.
In this article, the authors, who were the 3 principal investigators (PIs) for AANCART from 2010 to 2017, summarize the accomplishments associated with each of these aims and highlight achieved outcomes beyond expectations with respect to mitigating the unique, unusual, but unnecessary Asian American cancer health burden. The distinctiveness of this burden will be reviewed first as part of the context for AANCART's accomplishments.
The Federal Office and Management and Budget Directive 15 defines "Asian" as "A person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam." 7 Thus, cancer statistics reported for Asian Americans aggregate data from more than 21 million Asian alone or mixed race Asians, 8 which includes people who are both born in the United States and born in more than 30 countries of origin, are associated with at least 30 ethnic groups, and who speak more than 200 languages or dialects reflecting the diversity of the world's most populous and diverse continent. The heterogeneity within Asian Americans also spans socioeconomic and educational levels with among the highest proportions of income and educational attainment as well as the lowest proportions of income and educational attainment. As a composite category, Asian Americans or its prior designation of "Asian/Pacific Islander" (that included Native Hawaiians and Pacific Islanders) led the nation in the percentage of population increase for every census since 1970. Asian Americans continue to be the fastest growing racial/ethnic population in the United States. 9 Currently constituting 6% of the nation's population, Asian Americans are projected to exceed 40 million by 2050 or at least 9% of the US population. 10 With respect to the leading causes of death, the unique characteristic of Asian Americans has been that they are the first US racial population (beginning in 2000) 11 to experience cancer as the leading cause of death. 11 In 2012, Hispanics/Latinos also reported cancer as the leading cause of death among their ethnicity. 12 The cancer burden confronting Asian Americans is unusual in that infectious forms of cancer, (eg, those due to viruses, rather than noncontagious agents such as tobacco) disproportionately affect them. 13, 14 Among the viruses that disproportionately increase cancer risk for Asian Americans are hepatitis B and its linkage to hepatocellular carcinoma (primary liver cancer), 15, 16 human papilloma virus and its linkage to cervical cancer, 17 higher prevalence of nasopharyngeal cancer, 18 and Helicobacter pylori and its linkage to stomach cancer.
14 On an aggregate basis, liver cancer is the third leading cause of death for Asian males but does not rank among the top 5 causes of death for non-Hispanic whites. The aggregated percentage of deaths due to liver cancer among Asian males is 10.3% which exceeds the percentages of death among non-Hispanic whites due to prostate cancer (9.2%) and colorectal cancer (CRC) (9.1%). 19 Liver cancer deaths among Vietnamese males (22.3%) are more than twice the aggregate Asian male percentage. 19 At the same time, migration to the United States and its propensity for Asians to be "acculturated" appear to accelerate risks to chronic forms of cancer. 20 An unhealthy diet and a sedentary lifestyle increase the risk of developing CRC and breast cancer. For example, Chinese Americans who live in the San Francisco Bay Area have a higher incidence of CRC than Chinese people who live in China but a lower incidence than that of other ethnic populations in America. 21 Even though breast cancer rates in Asia are among the lowest in the world, highly acculturated USborn Japanese American women have breast cancer rates that surpass that of non-Hispanic white women. 22 However, the cancer burden confronting Asian Americans is also unnecessary in many respects. For Introduction instance, tobacco use-just as it is for all ethnic populations-is the most important preventable risk factor for lung cancer. Nevertheless, Asian American men smoke (14%) at least twice as much as Asian American women (6%); therefore, the aggregated smoking rate of 10% could be misleading. 23 Earlier detection of cancer through screening for CRC and viral hepatitis-related liver cancer may result in avoidable cancer deaths. In the case of those who have not been infected with hepatitis B and are not naturally immune, vaccination is a highly effective strategy to prevent the onset of HBV infection. 24 
MATERIALS AND METHODS
The data for this report were derived from multiple sources, including annual reports, peer-reviewed published papers, and information requests from trainees. The 3 PIs discussed AANCART's accomplishments from their respective perspectives.
The multiple PI plan was endorsed by the NCI as a means to leverage the strengths of experienced, senior leaders, who though they shared equal responsibility had differing roles based on their expertise. As the founding AANCART PI, Moon S. Chen Jr.'s familiarity with the SPN and CNP organizational patterns and the individuals involved allowed him to serve as the lead PI. However, with the demands of the new CNPC RFA, he recruited two other PIs. Tung Nguyen was recruited as the research PI to direct the research core, which included a pilot study for an early stage investigator and 3 community-based randomized, controlled trials. As a community leader and nationally recognized clinical leader, Edward A. Chow was recruited as the community PI to balance the 2 other academic-oriented PIs and focused on assuring that AAN-CART would always serve the community.
Organizationally, AANCART was considered an NCI-funded consortium comprised of a lead organization-the University of California, Davis-with consortium members being the University of California, San Francisco; the Chinese Community Health Resource Center; the University of California, Los Angeles; the University of Hawaii; the University of Washington; and the Hmong Women's Heritage Association. Geographically, these consortium members spanned California, Washington, and Hawaii. To execute NCI's charge to the CNPCs, AANCART included the Administrative Core (Julie Dang, Director), which functioned to coordinate and administratively support the Steering Committee and consortium; the Research Core (Tung Nguyen and Susan Stewart, Co-Directors), which planned and conducted the pilot study and 3 research studies with representation from all consortium members; the Outreach Core (Angela Sun, Director), which comprised community outreach directors representing the geographical regions; and the Training Core (Marjorie Kagawa-Singer, Shin-Ping Tu, and Moon S. Chen Jr., Co-Directors), which focused on mentees and trainees.
RESULTS

Achieving Specific Aims
Aim 1 was completed with the establishment of the administrative infrastructure for the National Center for Reducing Asian American Cancer Health Disparities. This infrastructure was built upon the prior cycles of AANCART, 4,5 which had instituted monthly conference calls of the Steering Committee comprising the PIs, NCI Program Director, and Directors of each Core (Administrative, Outreach, Research, and Training) as well as the regional or site PIs. The composition of the Steering Committee also assured representation from all geographic regions as well as a balance of members with academic perspectives and community perspectives. These calls provided the basis for priority setting, decision making, and follow-up essential to successful coordination.
To achieve Aim 2, the Outreach Core conducted ethnically specific and regionally based outreach (cancer awareness) that stemmed from needs assessments and community linkages. Rather than have each region conduct outreach to all Asian American groups in each region, AANCART set up populations of emphasis such that efforts focused on awareness, screening, and educational events involved specific populations within each region while not excluding anyone from the meetings. The population of emphasis in Sacramento was the Hmong; in San Francisco, Chinese and Vietnamese; in Los Angeles, Koreans; in Seattle, Cambodians; and in Hawaii, Filipinos. The decisions to emphasize which population in which region was based on factors such as the relative numbers of that population (eg, there are more Hmong in Sacramento than in the other AANCART regions) and the presence of AAN-CART community members from those regions who led their respective outreach activities. In many cases, AAN-CART developed the first culturally appropriate, linguistically specific, evidence-based materials designed to increase knowledge about and use of beneficial procedures to reduce cancer disparities and related comorbid conditions for Asian Americans of Chinese, Filipino Hmong, and Korean ancestry. These products are listed in Table 1 . Print materials, particularly the bilingual flip charts were used as part of the educational interventions to increase CRC screening for Hmong 25 Koreans, 26 and Filipinos 27 based on the previously conducted CRC screening intervention of Chinese. 28 Not included in Table 1 but produced by AAN-CART were flip charts and videos to educate Hmong, Korean, and Vietnamese populations on the importance of screening for hepatitis B and nutrition and physical activity 29, 30 that were part of the "Liver Cancer Control Interventions for Asian Americans project, which also was funded by the NCI Center to Reduce Cancer Health Disparities." For the greatest efficiency, awareness products supported the CRC intervention studies.
To achieve Aim 3, the Research Core supervised the conduct of the pilot research study and the full research study. Both of these studies were randomized controlled community intervention studies. The intervention component of the pilot research study which focused on the effect of the acceptability of donating biospecimens for cancer research among Chinese has been published. 31 The full research study was comprised of 3 localityspecific, community-based randomized controlled studies (RCTs) that assessed the effectiveness of lay health educators from the respective population of emphasis in increasing CRC screening. The localities and the respective populations of emphasis were Sacramento (Hmong), Los Angeles (Korean), and Honolulu (Filipino). Findings from the Hmong 25 Korean, 26 and Filipino 27 studies have been reported previously. In total, 12 articles attributed to AAN-CART or P01 funding have reported results of RCTs, with 2 additional reviews discussing RCTs (Table 2) .
These studies exceeded the requirements of Aim 3 to conduct, foster, and disseminate evidence-based intervention research to reduce the unnecessary cancer burden confronting Asian Americans.
To achieve Aim 4, the Training Core's objective, nurturing and mentoring NESIs in CBPR who submit peerreviewed proposals and obtain funding to conduct research to reduce health disparities was attained. All AANCART trainees in the current cycle are Asian American, but in previous cycles, non-Asians who focused on cancer disparities in Asian Americans were funded (Table 3) .
After funding, we were pleased to receive funding for 2 additional diversity trainees. As a demonstration of the community-academic research environment that AANCART created, we had other trainees who initiated research training careers. As these self-initiated mentees emerged, AANCART senior faculty volunteered mentoring to these trainees. They included 3 Master's level students who matriculated into doctoral programs at the University of Phoenix, the University of California, Davis, and the University of California, Berkeley. The other self-initiated trainee was appointed as an Assistant Professor at DePaul University. All trainees had multiple first author publications. Aim 4 was exceeded.
Unanticipated Outcomes and Avenues
Beyond meeting or exceeding the 4 aims promised to the NCI, AANCART colleagues also pursued other unanticipated avenues of outreach and research. Through administrative supplements or leveraged grants, AANCART extended itself to addressing participation of minorities, particularly Asian Americans in cancer clinical trials; extending AANCART's expertise in addressing Asian American participation in cancer clinical trials to enhancing participation of minorities in clinical trials for human immunodeficiency virus (HIV)-related malignancies; and developing the infrastructure for biospecimen donation for cancer research.
Increasing participation in cancer clinical trials
At the invitation of the National Institute on Minority Health and Disparities-funded Enhancing Minority Participation in (cancer) Clinical Trials (EMPaCT), AAN-CART at the University of California, Davis, served as a consortium member that included the University of Minnesota (lead); MD Anderson Cancer Center; Johns Hopkins University; and the University of Alabama at Birmingham. This led to educational products to introduce clinical trials to Chinese, Korean, Hmong, and Vietnamese individuals. A report documenting the importance of minority participation in cancer clinical trials was published in 2014 35 and was highlighted by the 
Enhancing participation in HIV-linked malignancy trials
At the invitation of the NCI Center to Reduce Cancer Health Disparities, supplemental funds allowed us to conduct focus groups of all racial/ethnic populations with respect to increasing participation of HIV-positive patients in clinical trials for HIV-related malignancies.
We collaborated with the University of Puerto Rico in developing a bilingual (Spanish/English) video on the advantages of participating in clinical trials for HIVpositive patients. 37 An RCT is underway in Puerto Rico to evaluate the effectiveness of this video on increasing patient accrual for HIV-related malignancies trials.
Encouraging biospecimen donations for risk factor assessment and cancer research
Using supplemental funds from the NCI, we conducted pioneering research on the perceptions of Chinese, Hmong, and Vietnamese lay public toward biospecimens. We collaborated with other CNPCs in publishing our findings with others who researched perceptions of whites and Hispanics. 38 We also applied our experience in collecting blood biospecimens to characterize various risk factors for hepatocellular carcinoma 39, 40 and diabetes 41 and are currently analyzing the potential of the genetic propensity toward liver cancer from the Hmong blood biospecimens we collected.
DISCUSSION
The purpose of this article is to describe AANCART's cumulative contributions to mitigating Asian American cancer health disparities with respect to the NCI's expectations and to highlight unanticipated outcomes. Our achievements demonstrate that tailoring language and culture by ethnicity improves approaches to mitigate cancer burden. Our achievements also exemplify the effectiveness of academic and community collaborations, including bringing new researchers from the community to partner with academia (see Table 3 ). AANCART concluded that liver cancer is the most important cancer health disparity confronting Asian Americans, 15, 16, 42 but other disparities also exist. 13, 14 To properly address these disparities, AANCART colleagues developed linguistically specific, culturally competent educational materials with community guidance specifically for hepatitis B screening and CRC screening (Table 1) . With CBPR as its foundation, AANCART colleagues implemented community-centered RCTs, the first of their kind for its Another legacy is exemplified by the numbers of NESIs, both originally named in our proposal and selfinitiated trainees. We believe that these self-initiated trainees would not have considered research careers were it not for the AANCART research culture, where they received mentoring from senior AANCART faculty. Based on their current trajectories, we anticipate that these trainees will be among the next generation of Asian American health disparities researchers.
We catalyzed national recognition for the importance of participation of minorities in cancer clinical trials; 35 we contributed to an educational intervention that appears to facilitate the participation of Puerto Rican HIV-positive, Spanish-speaking patients to join AIDS malignancy trials; 37 and through our research in biospecimen collection, we have significantly increased the numbers of biospecimens used to assessing risk for cancer and comorbid conditions in community settings. 38 Beyond using blood biospecimens for diagnostic purposes, we completed a pilot study using whole-exome sequencing that suggests a potential genetic explanation for the propensity of liver cancer in Hmong adults. 45 We believe AANCART could be a model for other programs focused on vulnerable populations. Lessons learned for being an effective model included being collaborative among Asian ethnicities in academe and community, tailoring evidence-based interventions based on language and culture, and having a supportive, highly committed but expanding cadre that contributes to the nurturing of NESIs.
Despite these developments, we acknowledge at least 3 limitations. First, time is a limitation. Even 17 years is insufficient to detect a decline in cancer mortality; however, we have demonstrated surrogate markers of risk reduction, eg, increased serological testing for HBV and CRC screening through community-based RCTs. Second, although the achievements by the trainees are already impressive, another decade may be needed to assess the true impact of AANCART's research culture. One challenge for this next generation of cancer researchers may be to validate more precise markers of cancer prevention, rather than using declines in mortality rates. Diminishing disparities to precision cancer prevention should be a goal. Third, space does not permit a more thorough presentation of both achievement of the Specific Aims and the unanticipated outcomes. Nevertheless, we believe we have presented a snapshot of a very healthy return on investment for the NCI's Center to Reduce Cancer Health Disparities.
In conclusion, funding from the NCI's Center to Reduce Cancer Health Disparities and the National Center on Minority Health and Health Disparities (the predecessor to the National Institute on Minority Health and Health Disparities) enabled AANCART's contributions to mitigating the cancer burden confronting Asian Americans. We present documentation based on published papers on exceeding the specific aims. This was achieved by reaching out to Asian Americans in their languages of origin and through culturally concordant approaches. We accomplished initiatives that were not proposed originally. In particular, we introduced the collection of blood biospecimens for cancer research as part of community screenings that were subsequently applied in ascertaining the potential of genetic determinants on liver cancer disparities. 46 In the words of a Chinese proverb: "A journey of a thousand miles begins with a single step." Many steps have been taken on this exciting journey.
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